Potential framework of the Global Leadership Initiative in Sarcopenia (GLIS) criteria based on muscle mass and/or strength for predicting survival in cancer patients: A nationwide multicenter cohort study
Clinical Nutrition · 2025
DOI: 10.1016/j.clnu.2025.04.021 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Nutrition, 2025. Verfasst von Zhenyu Huo und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Nutrition, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, 400042, China; Chongqing M…. Hauptthemen laut MEDLINE: Sarcopenia, Neoplasms, Muscle Strength, Muscle, Skeletal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Chongqing Municipal Health Commission.
Themen: Onkologische Pflege
Abstract (Originalsprache)
BACKGROUND: The Global Leadership Initiative on Sarcopenia (GLIS) was proposed recently by creating a widely recognized conceptual definition of sarcopenia, however, the diagnostic framework of GLIS in cancer patients remains unclear. This study aims to evaluate the potential framework of GLIS based on muscle mass and/or strength in cancer patients. METHODS: We performed a multicenter cohort study spanning from November 2012 to May 2020. Potential covariates were identified through univariate and multivariate analyses. The association between low muscle mass (LMM) and/or low muscle strength (LMS) with survival was estimated using Kaplan-Meier curves and Cox models. LMM was identified by lean mass index (LMI) or calf circumference (CC) while LMS was identified by hand grip strength (HGS). RESULTS: A total of 6471 cancer patients were included, with a median follow-up of 50.0 months. Both LMM-LMI or LMS (HR = 1.56; 95%CI: 1.42, 1.71; p < 0.001) and LMM-LMI plus LMS (HR = 2.01; 95%CI: 1.65, 2.44; p < 0.001) were associated with a lower overall survival (OS) compared with patients without sarcopenia. Similarly, both LMM-CC or LMS group (HR = 1.51; 95%CI: 1.37, 1.67; p < 0.001) and LMM-CC plus LMS group (HR = 1.45; 95%CI: 1.28, 1.63; p < 0.001) were associated with a lower OS. Age, alcohol, Nutritional Risk Screening 2002 (NRS2002) score, Karnofsky Performance Status (KPS) score, Tumor Node Metastasis (TNM) stage, cancer category, albumin, direct bilirubin, anticancer therapy plus sex were introduced as covariates in fully-adjusted Cox model. Multivariable-adjusted Cox models revealed that LMM-LMI or LMS was an independent prognosis factor for cancer patients (HR = 1.18; 95%CI: 1.07, 1.31; p = 0.001). LMM-LMI plus LMS also was an independent predictor for survival among cancer patients (HR = 1.58; 95 % CI: 1.30, 1.94; p < 0.001). CONCLUSION: The potential framework of GLIS based on muscle mass and/or strength was associated with survival in Chinese cancer patients. This research provides a simplified, clinically outcome-driven potential framework of sarcopenia, and offers new insights for the development of an operational definition of GLIS in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Nutrition, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, 400042, China; Chongqing Municipal Health Commission Key Laboratory of Intelligent Clinical Nutr…
- Department of Clinical Nutrition, The Thirteenth People's Hospital of Chongqing, Chongqing, 400053, China.
- Department of Epidemiology, College of Public Health, Zhengzhou University, Henan, 450001, China.
- Department of Gastrointestinal Surgery/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China; Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, 100038, China…
Förderung
- Chongqing Municipal Health Commission
Zitieren
APA
Huo, Z., Chong, F., Luo, S., Li, N., Tong, N., Lu, Z., Guo, J., Zhang, L., Lin, X., Zhang, M., Zhang, H., Shi, M., He, X., Liu, J., Song, C., Shi, H., & Xu, H. (2025). Potential framework of the Global Leadership Initiative in Sarcopenia (GLIS) criteria based on muscle mass and/or strength for predicting survival in cancer patients: A nationwide multicenter cohort study. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2025.04.021
Vancouver
Huo Z, Chong F, Luo S, Li N, Tong N, Lu Z, et al. Potential framework of the Global Leadership Initiative in Sarcopenia (GLIS) criteria based on muscle mass and/or strength for predicting survival in cancer patients: A nationwide multicenter cohort study. Clinical Nutrition. 2025. doi:10.1016/j.clnu.2025.04.021
BibTeX
@article{Huo2025,
author = {Huo, Zhenyu and Chong, Feifei and Luo, Siyu and Li, Na and Tong, Ning and Lu, Zongliang and Guo, Jing and Zhang, Ling and Lin, Xin and Zhang, Mengyuan and Zhang, Hongmei and Shi, Muli and He, Xiumei and Liu, Jie and Song, Chunhua and Shi, Hanping and Xu, Hongxia},
title = {Potential framework of the Global Leadership Initiative in Sarcopenia (GLIS) criteria based on muscle mass and/or strength for predicting survival in cancer patients: A nationwide multicenter cohort study},
journal = {Clinical Nutrition},
year = {2025},
doi = {10.1016/j.clnu.2025.04.021}
}
EUVIMED